1. Home
  2. NICE vs EXEL Comparison

NICE vs EXEL Comparison

Compare NICE & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NICE
  • EXEL
  • Stock Information
  • Founded
  • NICE 1986
  • EXEL 1994
  • Country
  • NICE Israel
  • EXEL United States
  • Employees
  • NICE N/A
  • EXEL N/A
  • Industry
  • NICE Computer Software: Prepackaged Software
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NICE Technology
  • EXEL Health Care
  • Exchange
  • NICE Nasdaq
  • EXEL Nasdaq
  • Market Cap
  • NICE 10.1B
  • EXEL 9.4B
  • IPO Year
  • NICE 1996
  • EXEL 2000
  • Fundamental
  • Price
  • NICE $155.48
  • EXEL $36.70
  • Analyst Decision
  • NICE Strong Buy
  • EXEL Buy
  • Analyst Count
  • NICE 14
  • EXEL 18
  • Target Price
  • NICE $231.64
  • EXEL $37.59
  • AVG Volume (30 Days)
  • NICE 672.9K
  • EXEL 2.8M
  • Earning Date
  • NICE 05-15-2025
  • EXEL 04-29-2025
  • Dividend Yield
  • NICE N/A
  • EXEL N/A
  • EPS Growth
  • NICE 32.29
  • EXEL 170.77
  • EPS
  • NICE 6.76
  • EXEL 1.76
  • Revenue
  • NICE $2,735,272,000.00
  • EXEL $2,168,701,000.00
  • Revenue This Year
  • NICE $9.20
  • EXEL $5.45
  • Revenue Next Year
  • NICE $7.43
  • EXEL $10.32
  • P/E Ratio
  • NICE $22.40
  • EXEL $20.85
  • Revenue Growth
  • NICE 15.05
  • EXEL 18.50
  • 52 Week Low
  • NICE $137.19
  • EXEL $20.14
  • 52 Week High
  • NICE $260.62
  • EXEL $40.02
  • Technical
  • Relative Strength Index (RSI)
  • NICE 51.40
  • EXEL 48.90
  • Support Level
  • NICE $138.74
  • EXEL $36.71
  • Resistance Level
  • NICE $161.19
  • EXEL $38.41
  • Average True Range (ATR)
  • NICE 4.45
  • EXEL 1.10
  • MACD
  • NICE 1.87
  • EXEL -0.18
  • Stochastic Oscillator
  • NICE 74.57
  • EXEL 21.43

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nice's CXone platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: